← Back to Cibo Flash
Earnings

Shineway Pharm (02877) announced interim results

  • RevenueRMB11.8bn
  • Net profitRMB4.7bn
  • Profit attributable to ownersRMB4.7bn
  • Revenue YoY-28.5%
  • Net profit YoY-23.7%
  • Depreciation & amortisationHK$70.9M
  • Capital expenditureHK$-2.0bn
  • Interest-bearing debtHK$3.3bn

Source Shineway Pharm

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect